Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
$13.37
+0.4%
$13.01
$10.95
$13.42
N/AN/A101,842 shs58,110 shs
BTC
ClearShares Piton Intermediate Fixed Income ETF
$91.37
+0.1%
$91.37
$98.48
$100.89
$29.70MN/A1,456 shs785 shs
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$80.97
-0.3%
$79.75
$65.18
$82.62
$157.89M1.225,087 shs3,295 shs
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$0.08
-11.1%
$0.11
$0.07
$1.28
$2.90M2.033.27 million shs1.82 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
-0.23%+2.78%+1.84%+5.39%+18.34%
BTC
ClearShares Piton Intermediate Fixed Income ETF
-0.09%+0.62%+0.16%-0.94%-7.90%
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
+1.11%+2.85%-0.43%+6.35%+22.45%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
+0.34%-0.78%+3.00%-41.79%+8,929,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
N/AN/AN/AN/AN/AN/AN/AN/A
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/AN/AN/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
N/AN/AN/AN/A
BTC
ClearShares Piton Intermediate Fixed Income ETF
0.00
N/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
0.00
N/A$87.868.50% Upside
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
$39.39MN/AN/AN/AN/AN/A
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$14.73M0.20N/AN/A$0.12 per share0.67

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
N/AN/A0.00N/AN/AN/AN/AN/A
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/A0.00N/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/A11.93N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-$9.64M-$3.82N/A1.15N/A-65.46%-150.14%-53.48%5/28/2024 (Estimated)

Latest NBY, BGT, FAB, BTC, and IXI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$0.95-$0.95-$0.57N/A$3.73 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
$1.4010.47%+22.54%N/A3 Years
BTC
ClearShares Piton Intermediate Fixed Income ETF
$0.020.02%N/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$1.481.83%N/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/A

Latest NBY, BGT, FAB, BTC, and IXI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2024
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
Monthly$0.1211.14%5/14/20245/15/20245/31/2024
4/1/2024
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
Monthly$0.1210.98%4/12/20244/15/20244/30/2024
3/1/2024
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
Monthly$0.1211.07%3/14/20243/15/20243/28/2024
3/20/2024
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
Quarterly$0.24303/21/20243/22/20243/28/2024
(Data available from 1/1/2013 forward)

Debt

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BlackRock Floating Rate Income Trust stock logo
BGT
BlackRock Floating Rate Income Trust
N/AN/AN/ANot Optionable
BTC
ClearShares Piton Intermediate Fixed Income ETF
147,000325,000N/ANot Optionable
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
147,0001.95 millionN/ANot Optionable
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
2436.06 million36.03 millionNot Optionable

NBY, BGT, FAB, BTC, and IXI Headlines

SourceHeadline
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial ResultsNovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
businesswire.com - May 9 at 4:05 PM
NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated by Analysts at StockNews.comNovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated by Analysts at StockNews.com
americanbankingnews.com - May 9 at 3:42 AM
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through AmazonNovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
businesswire.com - May 7 at 8:00 AM
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
businesswire.com - May 3 at 6:50 AM
NovaBay Pharmaceuticals (NYSE:NBY) Earns Sell Rating from Analysts at StockNews.comNovaBay Pharmaceuticals (NYSE:NBY) Earns Sell Rating from Analysts at StockNews.com
americanbankingnews.com - May 1 at 2:14 AM
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova SalesNovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
businesswire.com - April 22 at 6:57 AM
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder EquityNovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
businesswire.com - April 19 at 6:00 PM
NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call TranscriptNovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 28 at 9:16 PM
NovaBay Pharmaceuticals: Q4 Earnings InsightsNovaBay Pharmaceuticals: Q4 Earnings Insights
benzinga.com - March 26 at 10:00 PM
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial ResultsNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
finance.yahoo.com - March 26 at 10:00 PM
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
businesswire.com - March 25 at 6:38 PM
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
businesswire.com - March 14 at 8:00 AM
NioBay Metals closes option agreement to acquire Foothills propertyNioBay Metals closes option agreement to acquire Foothills property
markets.businessinsider.com - February 21 at 8:30 AM
A Guide To The Risks Of Investing In Novabay Pharmaceuticals Inc (NBY)A Guide To The Risks Of Investing In Novabay Pharmaceuticals Inc (NBY)
knoxdaily.com - January 31 at 8:40 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

BlackRock Floating Rate Income Trust logo

BlackRock Floating Rate Income Trust

NYSE:BGT
BlackRock Floating Rate Income Trust is a close ended fixed income mutual fund launched by BlackRoack Inc. The fund is co-managed by BlackRock Advisors, LLC and BlackRock Financial Management, Inc. It invests in the fixed income markets across the globe while focusing on the United States. The fund invests in bonds of companies operating across diversified sectors. It invests in corporate bonds with average effective duration of its portfolio will be no more than 1.5 years. The fund was formerly known as BlackRock Global Floating Rate Income Trust. BlackRock Floating Rate Income Trust was formed on August 30, 2004 and is domiciled in the United States.

ClearShares Piton Intermediate Fixed Income ETF

NYSEARCA:BTC
First Trust Multi Cap Value AlphaDEX Fund logo

First Trust Multi Cap Value AlphaDEX Fund

NASDAQ:FAB
The First Trust Multi Cap Value AlphaDEX Fund (FAB) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Multi Cap Value index. The fund tracks an index that uses fundamental factors to select and weight value stocks from the Nasdaq US Select Indices. FAB was launched on May 8, 2007 and is managed by First Trust.
NovaBay Pharmaceuticals logo

NovaBay Pharmaceuticals

NYSE:NBY
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.